CEO: Tom Frohlich
Employees: 50
IPO: Apr 29, 2025
Prijs
€ 16,02
Verandering
▲ € 1,97
14,02%
Marktkapitalisatie
522,67M
Dagbereik
€ 13,93
€ 16,23
52-Weeksbereik
€ 6,57
€ 100,10
Volume
2.228.725
50D / 200D Gem.
€ 14,64
€ 11,33
Vorige Slotkoers
€ 14,05
Quick Summary
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -94,89M
PEG of 0,04 suggests growth is underpriced
Dividend yield of 15,55% — meaningful income
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-62,31%
Onder sectorgemiddelde (3,61%)
ROIC-25,55%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Onder sectorgemiddelde (0,23)
Current Ratio20,33
Interest Coverage0,00
Waardering
P/E Ratio
-4,10
Onder sectorgemiddelde (0,23)
Forward P/EN/A
P/B Ratio1,57
EV/EBITDAN/A
Dividend Yield15,55%
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (638 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4,1 | 0,2 |
| P/B | 1,6 | 2,9 |
| ROE % | -62,3 | 3,6 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 9,6 |
| D/E | 0,0 | 0,2 |
Dividend History
Yield
15,55%
Payout Ratio
-0,59%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -127,41M |
| ROE | -62,31% | ROA | -36,43% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -94,89M |
| ROIC | -25,55% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 20,33 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 15,55% | Payout Ratio | -0,59% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4,10 | Forward P/E | N/A |
| P/B Ratio | 1,57 | P/S Ratio | N/A |
| PEG Ratio | 0,04 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -18,15% | ||
| Market Cap | 522,67M | Enterprise Value | 434,95M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -127,41M | -69,63M | -75,52M | -51,51M | -22,96M |
| EPS (Diluted) | -4,06 | -85,26 | -100,38 | -73,67 | -32,96 |
| Gross Profit | -26.000,0 | -282.000,0 | -96.000,0 | -68.000,0 | -15.000,0 |
| Operating Income | -113,54M | -74,60M | -81,41M | -53,24M | -23,02M |
| EBITDA | -113,54M | -69,29M | -75,37M | -51,42M | -22,95M |
| R&D Expenses | 93,12M | 53,19M | 64,22M | 38,62M | 14,99M |
| SG&A Expenses | 20,40M | 21,13M | 17,09M | 14,55M | 8,02M |
| D&A | 26.000,0 | 282.000,0 | 96.000,0 | 68.000,0 | 15.000,0 |
| Interest Expense | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Income Tax | 58.000,0 | 55.000,0 | 56.000,0 | 25.000,0 | 3.000,0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 349,78M | 80,33M | 127,42M | 135,30M | 175,36M |
| Total Liabilities | 17,26M | 3,90M | 17,96M | 8,56M | 2,95M |
| Shareholders' Equity | 332,52M | 76,43M | 109,46M | 126,74M | 172,42M |
| Total Debt | 724.000,0 | 417.000,0 | 675.000,0 | 1,09M | 574.000,0 |
| Cash & Equivalents | 88,44M | 33,75M | 23,49M | 22,40M | 54,20M |
| Current Assets | 336,16M | 80,12M | 124,23M | 131,50M | 174,33M |
| Current Liabilities | 16,54M | 3,83M | 17,64M | 7,78M | 2,55M |